FDA Expands Use of COVID-19 Vaccine Booster Dose in Eligible Populations
The US Food and Drug Administration has granted approval for administration of COVID-19 vaccine booster dosage, upgrading the emergency use
Read more
Latest
GSK Reveals Plan for Consumer Healthcare Company UK-based HQ
GSK revealed ideas for a large new UK-based headquarters and global campus for the new Consumer Healthcare company, after the
Read more
Genentech’s Investigational Antibody Wins BTD for Alzheimer’s Treatment
Genentech’s investigational antibody for the treatment of early-stage Alzheimer’s disease, Gantenerumab, has been granted Breakthrough Therapy Designation by the U.S.
Read more
Tezepelumab gets ODD in the US for Eosinophilic Esophagitis
Tezepelumab, developed by AstraZeneca in collaboration with Amgen, has been granted Orphan Drug Designation (ODD) in the US FDA for
Read more
WHO Endorses GlaxoSmithKline’s Breakthrough Malaria Vaccine
The World Health Organization on Wednesday endorsed the groundbreaking GlaxoSmithKline Malaria vaccine for children at risk reinvigorating the fight against
Read more
Merck and Ridgeback’s Oral Antiviral Molnupiravir Can Halve COVID-19 Risk of Hospitalisation
Interim Analysis of Phase 3 Study shows Merck and Ridgeback’s investigational oral antiviral Molnupiravir has reduced the risk of hospitalization
Read more
FDA OK’s Tecartus® CAR T-cell Therapy for B-cell Acute Lymphoblastic Leukemia
Kite Pharma, a Gilead Company, announced on Friday that the U.S. FDA has granted approval for CAR T-cell therapy Tecartus®
Read more
Rosalind Franklin Institute, Novel Biological Imaging Technologies, UK
The Rosalind Franklin Institute, a new research institute dedicated to developing novel technologies to tackle important health research challenges has
Read more
FDA Approves Antibody-drug Conjugate TIVDAK™ for Recurrent or Metastatic Cervical Cancer
Genmab A/S and Seagen Inc. revealed that the first and only approved antibody-drug conjugate (ADC) known as TIVDAK™ (tisotumab vedotin-tftv),
Read more
FDA Committee Recommends COMIRNATY® Booster for Emergency Use in People 65+
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the FDA’s Vaccines and Related Biological Products Advisory Committee
Read more